Related Experiment Video
Updated: May 9, 2026
07:53
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
An exploration of pathways involved in lung carcinoid progression using gene expression profiling
Dorian R A Swarts1, Leander Van Neste, Mieke E R Henfling
1Department of Molecular Cell Biology, GROW - School for Oncology & Developmental Biology, Maastricht University Medical Center, PO Box 616, 6200 MD Maastricht, The Netherlands.
Carcinogenesis
|August 10, 2013
Summary
Researchers identified key gene expression changes in pulmonary carcinoids linked to poor prognosis. These findings reveal new pathways driving tumor progression and potential therapeutic targets for better patient outcomes.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Pulmonary carcinoids are neuroendocrine tumors with generally good prognoses.
- Mechanisms driving pulmonary carcinoid progression remain largely unknown.
- Understanding progression pathways is crucial for identifying therapeutic targets.
Purpose of the Study:
- To identify gene expression profiles and pathways associated with pulmonary carcinoid progression.
- To validate potential prognostic and therapeutic targets in pulmonary carcinoids.
Main Methods:
- Comparative gene expression profiling of tumors from patients with favorable vs. poor outcomes.
- Validation of differentially expressed genes using quantitative real-time PCR.
- Survival analysis and immunohistochemistry to assess prognostic significance.
Main Results:
- A significant number of downregulated genes in poor-prognosis tumors were located on chromosome 11q.
- Upregulated genes involved in mitotic spindle checkpoint, chromosomal passenger complex (CPC), and BRCA-Fanconi anemia pathway were identified.
- BIRC5 (survivin), BUB1, CD44, IL20RA, KLK12, and OTP were independent predictors of patient outcome.
- Aurora B kinase and survivin showed upregulation in high-grade carcinomas.
Conclusions:
- Novel pathways, including those on chromosome 11q and mitotic regulation, are implicated in pulmonary carcinoid progression.
- Several genes, notably survivin, serve as strong prognostic indicators.
- Aurora B kinase and survivin represent potential therapeutic targets for high-grade pulmonary carcinomas.
